GSK plc (LON:GSK)
1,916.50
-4.00 (-0.21%)
Jul 15, 2026, 4:48 PM GMT
GSK plc Employees
GSK plc had 66,841 employees as of December 31, 2025. The number of employees decreased by 1,788 or -2.61% compared to the previous year.
Employees
66,841
Change (1Y)
-1,788
Growth (1Y)
-2.61%
Revenue / Employee
490.42K GBP
Profits / Employee
87.21K GBP
Market Cap
76.32B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 66,841 | -1,788 | -2.61% |
| Dec 31, 2024 | 68,629 | -1,583 | -2.25% |
| Dec 31, 2023 | 70,212 | 812 | 1.17% |
| Dec 31, 2022 | 69,400 | -20,696 | -22.97% |
| Dec 31, 2021 | 90,096 | -3,970 | -4.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 96,100 |
| Haleon | 24,535 |
| Spire Healthcare Group | 17,800 |
| Smith & Nephew | 16,988 |
| Convatec Group | 10,910 |
| Hikma Pharmaceuticals | 9,400 |
| CVS Group | 9,000 |
| Genus | 3,190 |
GSK plc News
- 2 days ago - GSK's Jemperli meets main goal in mid-stage rectal cancer trial - Reuters
- 5 days ago - GSK's targeted cancer therapy shows positive results in late-stage study - Reuters
- 7 days ago - Alector and GSK partnership to end after dementia, Alzheimer's drug failures - Reuters
- 8 days ago - Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs - Reuters
- 4 weeks ago - Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) - Business Wire
- 4 weeks ago - US FDA approves GSK's oral antibiotic for drug-resistant UTIs - Reuters
- 4 weeks ago - Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC - CNBC
- 4 weeks ago - Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal - Reuters